Clear The Air News Tobacco Blog Rotating Header Image

September, 2015:

CSU researcher studies e-cigarettes being gateway to tobacco

http://www.healthcanal.com/substance-abuse/66580-csu-researcher-studies-e-cigarettes-being-gateway-to-tobacco.html

A Colorado State University faculty member was involved in a new study showing that teens who use e-cigarettes are more likely to start smoking combustible types of tobacco products, like cigarettes, cigars and hookah.

That study, “Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence,” focused on 2,530 14-year-old students at 10 public high schools in Los Angeles who had never tried combustible tobacco. The researchers separated the students into two groups: 222 who acknowledged using e-cigarettes in the past and 2,308 who said they’d never tried them. Six months later, about 31 percent of the group that had reported using e-cigarettes said they had used a combustible tobacco product, while only 8 percent of the non-users had tried combustible tobacco.

“Sure enough, the kids who had used e-cigarettes were more likely to start using combustible tobacco,” said Riggs, a co-investigator who collaborated on the research design and data analysis for the project. “Results provide support for the hypothesis that e-cigarettes can be a stepping stone to combustible tobacco use.”

Growing health concern

Riggs said that while the use of e-cigarettes in Colorado is sometimes overshadowed by the legalization of marijuana, they represent an emerging public health concern.

“The perception is that e-cigarettes are less harmful because they contain fewer known carcinogens,” he said. “But they still contain nicotine, the addictive chemical which contributes to dependence. We are particularly concerned with adolescent nicotine use because the adolescent brain appears to be more susceptible to addiction than the adult brain.”

Exacerbating the problems with the growing popularity of e-cigarettes is that they can be flavored, making them even more appealing to youth.

Riggs, whose research expertise is in understanding adolescent brain development and its role in risk-taking behavior, said the study does not definitively mean that e-cigarettes caused the kids to start smoking, because other factors could be involved. But it’s a strong indication that e-cigarettes can act as a gateway.

He said one logical next step for the researchers is to examine the causal pathways linking e-cigarette use to combustible tobacco use.

“What is it about these youth, or their environments, that makes them more likely to transition to combustible use?” he asked.

The study was part of a larger project called the Health and Happiness Study, a five-year $3.5 million research grant funded by the National Institute of Drug Abuse. The principal investigator on the study was Adam Leventhal of the Department of Preventive Medicine at the University of Southern California.

The Department of Human Development and Family Studies is in CSU’s College of Health and Human Sciences.

India may be grilled at WHO meet on failure to implement larger pictorial warnings on tobacco packs

http://timesofindia.indiatimes.com/india/India-may-be-grilled-at-WHO-meet-on-failure-to-implement-larger-pictorial-warnings-on-tobacco-packs/articleshow/48781484.cms

NEW DELHI: India may have to face tough questions on tobacco control at the upcoming south-east Asia regional committee meeting of the World Health Organization next week.

Assessment of tobacco control measures taken by various countries in the region is among the top agendas to be taken up for detailed discussion during the meeting, sources said.

The meeting, which will take place in Dili in Timor Leste, will be attended by health ministers from 11 countries of the south-east Asia region including Indian health minister J P Nadda.

“Accelerating efforts to protect people against tobacco is one of the key topics for discussion at the meet. It is most likely that India will have to explain its position in the context of delay in implementation of the larger pictorial warnings on packs of tobacco products,” said an official, who is going to attend the WHO meeting.

The health ministry had earlier set a deadline of April 1 to increase the size of pictorial warnings on packs of tobacco products. A notification to this effect was also issued allowing time to manufacturers to prepare for the implementation. However, following interim recommendations by a Parliamentary Committee on Subordinate Legislation examining the proposed amendments to the Cigarettes and Other Tobacco Products Act, 2008, the ministry had put the final notification for the implementation on hold. The committee had sought more time to do stakeholder consultation and submit its final report to the health ministry.

Though, the ministry has maintained all through that it is determined to take stringent measures in order to control consumption of tobacco products, the delay in implementing larger pictorial warnings triggered criticism against the government.

Despite pressure from the civil society as well as the international community, the government has also failed to indicate a deadline for the committee to submit its recommendation or to say how long the ministry will wait before issuing its final order.

Though, the committee recently held consultations with civil society as well as industry players, no resolution has been arrived at so far. Meanwhile, the agriculture ministry has also given its consent to the proposal for larger pictorial warnings.

Sources said now India may again have to explain its move to satisfy queries and concerns from the international community at Dili.

Apart from tobacco, the meeting will also witness discussions on post-2015 Global Sustainable Development Goals, and expanding effective services with stronger health workforce.

The Regional Committee, the highest policy making body of WHO in the region, will also deliberate on anti-microbial resistance, an issue which needs urgent attention and action.

Eliminating neglected tropical diseases like kala-azar, leprosy and yaws; adapting and implementing the End Tuberculosis strategy; the way forward for preventing and controlling cancer; and sustainable universal health coverage will be other areas of focus at the meeting.

The Lancet attacks UK health agency’s claim that e-cigarettes are 95% safer than tobacco

http://arstechnica.co.uk/science/2015/09/the-lancet-attacks-uk-health-agencys-claim-that-e-cigarettes-are-95-less-harmful-than-tobacco/

Health agency’s report on e-cigarettes used shaky evidence, ignored conflicts of interest.

An editorial in the current issue of The Lancet criticises Public Health England (PHE) for using weak evidence in its recent review of evidence on e-cigarettes, and a press release that followed.

In particular, The Lancet takes aim at the claim that e-cigarettes are around 95 percent less harmful than tobacco. It argues that the evidence for this statistic is weak, and that it originates with researchers who have relevant conflicts of interest.

Weighing up the potential benefits and harms of e-cigarettes has become an important public health question. The PHE report, authored by addiction researchers at King’s College London and Queen Mary University of London, makes the case that e-cigarettes are substantially less harmful than cigarettes, and seem to help smokers to quit more successfully.

This means, the report argues, that e-cigarettes could be very helpful in reducing smoking in the UK, lowering smoking-related death and disease while bringing down public health costs. However, according to the report, public perception of e-cigarettes is an obstacle. Surveys suggest that people are increasingly nervous about potential harm from e-cigarettes, with many people reporting that they think of them as “just as harmful” as cigarettes.

“There is a need to publicise the current best estimate that using EC is around 95 percent safer than smoking,” the report suggests. And publicising is what PHE did: a press release went out entitled “E-cigarettes around 95 percent less harmful than tobacco.” It was picked up widely in the media, with some reports suggesting that the figure was established directly by the PHE review.

The horse’s mouth

It wasn’t. The report cites two references for the figure: a paper in the journal European Addiction Research, and a review (PDF) of e-cigarette evidence presented to the UK’s All Party Parliamentary Group on Smoking and Health. The review in turn cites the European Addiction Research paper as its source for the statistic, so it’s safe to assume that this paper is where it originated.

The paper, authored by a group of scientists led by addiction researcher David Nutt, was the result of a collaboration exploring the harms of nicotine products. To estimate how harmful tobacco and other nicotine products are, the group took into account harm to the user (such as disease and addiction) and harms to non-users (like disease and environmental degradation).

The scores of various products were calculated, with cigarettes notching up a score of 99.6 out of a possible hundred, and e-cigarettes scoring only 4. However, Nutt and his co-authors note a number of caveats that encourage caution with these results. Most importantly, they note that there just isn’t much evidence available.

The estimated harms of nicotine products.

The estimated harms of nicotine products.

They go so far as to say that there is a “lack of hard evidence for the harms of most of the products on most of the criteria.” In other words, they were estimating. Estimating is a useful starting point, but it’s shaky ground for a litany of headlines. It’s even shakier ground when you consider that the paper declared relevant conflicts of interest for three of its 11 authors.

Of course, conflicts of interest don’t necessarily mean that the research is shady: that’s why they’re often declared right out in the open, on the paper itself. But the conflicts of interest combined with the weaknesses in the estimates of harm should invite caution about the conclusions, The Lancet argues: “the reliance by PHE on work that the authors themselves accept as methodologically weak raises serious questions not only about the conclusions of the PHE report, but also about the quality of the agency’s peer review process.”

Evidence and public perception

The authors of the PHE report responded to the editorial, arguing that its criticisms were based on “perceived flaws in one of the 185 references we used, ignoring the rest of our 111 page document.” There was a great deal more in the report, they write, which delved into evidence on how good e-cigarettes are at helping people quit, whether they’re likely to encourage people to start smoking, and other relevant questions.

The report’s authors also offer different grounds for the contested statistic: that the compounds we know to be harmful in cigarettes are either absent in e-cigarettes, or present at levels below 5 percent of their cigarette doses. Meanwhile, nothing that’s in e-cigarettes (but not cigarettes) has been shown to be harmful (yet). There’s no source cited for these calculations, and it’s not clear why the authors are claiming a different source for the statistic from the one they cited in their original report.

The public misinformation about the harms of e-cigarettes, combined with the potential benefit they hold for helping people to quit, justifies the publicity surrounding the “95 percent” statistic, the authors argue. They’re backed up by PHE directors in a further response to the editorial, arguing that other important findings, like the growing perception of harm from e-cigarettes, have been neglected in the critique.

The debate here really separates into two separate issues. The first is about the actual evidence for harms and benefits of e-cigarettes, which is still a very hazy picture. It’s still too early to know what the long-term effects might be, and the evidence for how helpful they are for quitters is mixed—even according to the review cited by the PHE report. Moreover, a recent Journal of the American Medical Association paper reported that we might be optimistic in thinking that e-cigarettes don’t get people started on smoking: they found that teenagers who had smoked e-cigarettes were more likely to start smoking tobacco.

The second multifaceted issue, which is less easily resolved by lots of long-term research, is about public information, over-hyped and uncritical reporting in the media, and the over-hyped press releases underlying that naive media coverage. Minds can be slow to change on matters of public health, and the ethics of reporting shaky statistics that could shape health perceptions for years to come are worthy of The Lancet’s scrutiny.

E-cigarettes: Public Health England’s evidence based confusion?

Download (PDF, 31KB)

US health watchdog to take legal action against e-cigarette makers

http://www.theguardian.com/us-news/2015/sep/02/e-cigarette-manufacturers-california-health-watchdog

A health watchdog is to take legal action in California against the manufacturers of some of the best-known brands of e-cigarettes, following tests to establish the levels of toxic chemicals they contain. The Center for Environmental Health (CEH) says its tests found that nearly 90% of the companies had at least one brand that produced high levels of one or both of the cancer-causing chemicals formaldehyde and acetaldehyde.

In the first ever large lab-testing of e-cigarettes on the market, the CEH found that most – 50 of 97 products examined – contained high levels of one or both chemical. The lab tests and legal action will fuel the battle raging over e-cigarettes. While supporters say they could help thousands of people give up the far more dangerous tobacco-filled conventional cigarettes, others worry about the chemicals they contain. Such suspicions are fuelled by the involvement of major tobacco companies in the e-cigarette market. Critics say e-cigarettes may be a stalking horse for Big Tobacco, in order to rehabilitate the act of smoking.

The CEH said its lab tests of 97 e-cigarette and vaping products revealed levels of formaldehyde and acetaldehyde that violated California’s safety standards. It said this was the first time e-cigarettes had been tested by simulating their real-world use. “For decades, the tobacco industry mounted a campaign of lies about cigarettes, and now these same companies claim that their e-cigarettes are harmless,” said Michael Green, executive director of CEH. “Anyone who thinks that vaping is harmless needs to know that our testing unequivocally shows that it’s not safe to vape.

“This is especially troubling given the reckless marketing practices of the e-cigarette industry, which targets teens and young people, and deceives the public with unfounded health and safety claims. Our legal action aims to force the industry to comply with the law and create pressure to end their most abusive practices.” CEH is invoking California’s consumer protection law, known as Proposition 65. Earlier this year, the watchdog started legal action against the companies for failing to warn users about the risks of nicotine in the products.

The non-profit organisation purchased e-cigarettes, e-liquids and other vaping products from major retailers including RiteAid and 7-Eleven, and from many online retailers and Bay Area vape shops between February and July 2015. It commissioned an independent lab accredited by the American Association for Laboratory Accreditation to test 97 products, including 15 disposable “cigalikes” e-cigarettes, 32 cartridge devices and 50 refillable devices, for formaldehyde and acetaldehyde. The two chemicals are known to cause cancer and are also linked to genetic damage, birth defects and reduced fertility. The lab used standard smoking machines that simulate how consumers use the products. Almost 90% of the companies whose products were tested (21 of 24 companies) had one or more products that produced hazardous amounts of one or both of the chemicals, in violation of California law. The testing showed that 21 products produced a level of one of the chemicals at more than 10 times the state safety standard, and seven products produced one of the chemicals at more than 100 times the safety level. The CEH testing found high levels of the chemicals even in several nicotine-free varieties. For example, one nicotine-free product produced acetaldehyde at more than 13 times the state legal safety threshold and formaldehyde at more than 74 times the threshold.

Men in China face increasing tobacco-related cancer risks

http://medicalxpress.com/news/2015-09-men-china-tobacco-related-cancer.html

In China, smoking now causes nearly a quarter of all cancers in adult males. The finding comes from a large study published early online in Cancer, a peer-reviewed journal of the American Cancer Society, as part of a Special Issue on Lung Cancer in China. High uptake rates of cigarette smoking in teenaged males and continued use in adulthood foreshadow even greater tobacco-related cancer risks for the nation.

Tobacco-related deaths have been declining steadily in most developed countries; however, China now produces and consumes about 40 percent of the world’s cigarettes, with much of the rapid increase taking place since the early 1980s, involving almost exclusively only men.

To get a sense of the current smoking-related cancer risks in China, a research team led jointly by Professor Zhengming Chen, DPhil, of the University of Oxford in the UK and Professor Liming Li, MD, of the Chinese Academy of Medical Sciences in China, analyzed data from a nationwide prospective study called the China Kadoorie Biobank, which recruited 210,259 men and 302,632 women aged 30 to 79 years from 10 areas of China from 2004 to 2008. The study recorded approximately 18,000 new cancers during seven years of follow-up.

Among the major findings:

· Sixty-eight percent of men in the study were smokers, and they had a 44 percent increased risk of developing cancer compared with nonsmokers.
· This excess risk accounted for 23 percent of all cancers that arose between the ages of 40 and 79 years, with significantly elevated risks of cancers of the lung, liver, stomach, esophagus, and a collection of five other minor sites.
· Among ex-smokers (6.7%) who had stopped by choice, there was little excess cancer risk within 15 years after quitting.
· In contrast to men, only three percent of females in the study were smokers, and they experienced a 42 percent increased risk of cancer compared with nonsmokers.
· Smoking causes an estimated 435,000 new cancers (360,000 in men and 75,000 in women) each year in China.

“The tobacco-related cancer risks among men are expected to increase substantially during the next few decades as a delayed effect of the recent rise in cigarette use, unless there is widespread cessation among adult smokers,” the authors wrote. The study also noted that the first generation of men in China to experience the full extent of tobacco risks will probably be those who were born during the 1970s or 1980s, who reached adulthood when cigarette consumption was high. By contrast, this is the least exposure for the female generation in China. “If smoking rates remain low in women, tobacco may soon be responsible for most of the difference in life expectancy between men and women in China. Widespread smoking cessation offers China one of the most effective, and cost-effective, strategies for avoiding cancer and premature death over the next few decades” said Professor Zhengming Chen, the lead author and principal investigator of the China Kadoorie Biobank.

Brain Differences Seen With Combined Cannabis, Tobacco Use

http://www.medscape.com/viewarticle/850461

The use of cannabis and tobacco in combination may have unique effects on the brain and memory that in some ways contradict established neural responses, a new study suggests.

Imaging showed smaller hippocampal volumes, and testing showed worse memory among participants who used cannabis alone or with tobacco in comparison with nonusers, but smaller volumes were associated with better memory among users of marijuana plus tobacco.

The findings underscore the need to include the likelihood of comorbid tobacco use in cannabis research.

“Approximately 70% of individuals who use marijuana also use tobacco,” said principal investigator Francesca Filbey, PhD, director of cognitive neuroscience of addictive behaviors at the Center for Brain Health, in New York City, in a press statement.

“Our findings exemplify why the effects of marijuana on the brain may not generalize to the vast majority of the marijuana-using population, because most studies do not account for tobacco use.”

Their report was published this month in the journal Behavioural Brain Research.

Total Hippocampal Volumes

The study involved four groups of adults from two larger studies conducted at the University of New Mexico, in Albuquerque, which included cannabis-only users (n = 36), tobacco-only users (n = 19), combined cannabis and tobacco users (n = 19), and non–using healthy control participants (n = 16).

Criteria for cannabis users’ inclusion was reported use of cannabis at least four times per week during the past 6 months, verified by urinalysis. Tobacco users’ criteria included having used tobacco 10 or more times daily, verified by carbon monoxide breath monitor, and having had fewer than 3 months of abstinence in the past year.

After controlling for brain size and recent alcohol use, MRI showed smaller total hippocampal volumes among participants who used cannabis and tobacco, compared with the tobacco-only users and the control participants.

Interestingly, the reductions in hippocampus size in the combination group of cannabis and tobacco users were not significantly different from those of users of cannabis alone.

“It was surprising that this was not significantly different,” Dr Filbey told Medscape Medical News. “It is possible that with a large sample size, we may be able to detect a difference.”

Even more unexpected were findings showing that although in the nonuser control individuals, there was a trend linking larger hippocampal volume with improvements on memory scores, the users of cannabis and tobacco in combination showed worse memory and delayed recall scores that were associated with larger, not smaller, hippocampal volumes (P = .05 and P = .04, respectively), with scores improving with smaller hippocampal size.

“Taken together, the [cannabis and tobacco] users exhibited abnormal links between hippocampal volume and memory scores, and these relationships significantly deviated from the same patterns among control subjects,” the authors write.

The cannabis and tobacco users nevertheless had the smallest hippocampal volumes of the four groups, and they also had the lowest memory performance.

Dr Filbey speculated that the abnormal findings on hippocampal size and memory in cannabis and tobacco users could stem from an effect seen before with nicotine.

“It is possible that we may be seeing cognitive-enhancing effects of nicotine on memory function that is greater in those with smaller hippocampal volumes,” she said.

“Studies have found that this enhancing effect from nicotine is greater in those with greater impairment.”

Unusual Neuronal Effect

The findings suggest that a highly unusual neuronal effect can take place with the combination of cannabis and tobacco use, said Frank J. Vocci, PhD, coeditor of the American Society of Addiction Medicine’s Journal of Addiction Medicine and president of Friends Research Institute, Inc, in Baltimore, Maryland.

“This is certainly counterintuitive,” he told Medscape Medical News. “It strikes me as odd that you would get essentially a good response in the combination users group [in terms of memory], so there clearly is something going on that isn’t quite understood between nicotine and marijuana users and memory that has to be worked out,” he said.

“Small hippocampal volume is not considered to have a beneficial effect, so it certainly is an intriguing finding and needs replication in a larger study.”

The study’s authors have disclosed no relevant financial relationships. Dr Vocci has been a consultant for Reckitt-Benckiser Pharmaceuticals and for generic manufacturers of buprenorphine products. He has also been an investigator and consultant for buprenorphine studies funded by Braeburn Pharmaceuticals and Titan Pharmaceuticals. All of Dr Vocci’s consulting fees go to his employer, Friends Research Institute, Inc.

The truth about the tobacco industry …in its own words

Download (PDF, 381KB)

HK Customs detects smuggling of 7 mln HK dollars illicit cigarettes

http://www.ecns.cn/2015/09-02/179645.shtml

Xinhua Editor: Gu Liping

Hong Kong Customs detected a suspected smuggling case involving illicit cigarettes worth about 7 million HK dollars (about 900,000 U.S. dollars) with a duty potential of about 5 million HK dollars, a Customs spokesmam said here on Tuesday.

Customs officers intercepted an incoming lorry at Lok Ma Chau Control Point on Tuesday, and they found about 2.6 million sticks of suspected illicit cigarettes in 210 carton boxes after thorough inspection. A 40-year-old male driver was arrested.

The spokesman said the operation showed the effectiveness of the enforcement strategy, especially the escalated enforcement actions against smuggling activities at source.

Under the Import and Export Ordinance, smuggling is a serious offence in Hong Kong. The maximum penalty is a fine of 2 million HK dollars and imprisonment for seven years.

Could Tobacco Carveout Kill TPP?

http://blogs.rollcall.com/wgdb/could-tobacco-carveout-kill-tpp/

By Matthew Fleming and Niels Lesniewski

The Trans-Pacific Partnership’s rocky road in Congress faces a fresh threat from tobacco-state senators.

A brief trip down memory lane: Trade Promotion Authority passed with 62 votes in June, paving the way for a simple-majority threshold for the 12-nation trade deal.

But to get there, TPA required legislative jujitsu packaged with other bills, complex vote sequences and a ping-pong with the House to draw enough votes.

TPA endured one Democratic filibuster. It dealt with a messy human trafficking provision as well as language combating currency manipulation. It sustained vociferous opposition from most Democrats and unions and Republican opposition to the relinquishment of Congressional power.

And despite all of that, it’s tobacco’s status as a significant cash crop in Kentucky that could snuff out TPP in the end.

Reuters reported the administration had been considering allowing tobacco to be carved out of the investor-state dispute settlement, which, among other things, would give tobacco companies little protection against stiff regulation by trade partners, like Australia’s ban on branded cigarette packs.

Senate Majority Leader Mitch McConnell of Kentucky, along with Republican Sens. Richard M. Burr and Thom Tillis of North Carolina, have repeatedly protested even the vague notion of a provision targeting tobacco.

Both in person and through correspondence, McConnell has pressed U.S. Trade Representative Michael Froman throughout the negotiations to ensure there is no provision targeting tobacco, even citing the crop’s role in “important biomedical research.”

“As you know, I am very optimistic about the potential for Kentucky’s manufacturing workers and farmers — including its thousands of tobacco growers — to benefit from new export opportunities facilitated by a completed TPP agreement,” McConnell wrote in a July 30 letter to Froman. “It is essential as you work to finalize the TPP, you allow Kentucky tobacco to realize the same economic benefits and export potential other U.S. agricultural commodities will enjoy with a successful agreement.”

Needless to say, not many things happen in the Senate if the majority leader doesn’t want them to happen, and he’s calling tobacco protections “essential.”

It’s unclear where Kentucky’s junior senator stands: Rand Paul, a Republican running for reelection as well as the GOP presidential nomination. His office did not respond to multiple requests for comment.

Burr, who sits on the Finance Committee, which includes trade in its jurisdiction, told CQ Roll Call he’d received assurances from Froman that tobacco would not be excluded from protections in the deal.

Burr, who took the strongest position out of the three senators, asked again from Froman for reassurance that tobacco would be treated differently and vowed to do everything possible to derail the trade legislation if tobacco isn’t protected.

“I was told it wouldn’t be in there, that I didn’t need to worry about it,” Burr told CQ Roll Call. “And that was before I cast a crucial vote on TPA, which changed the [vote threshold] from 60 to 51. I made a promise to him before that if it was in there I’d do everything in my power to kill the TPP. And I will.”

Tillis argued in a letter to Froman in early August that a tobacco carveout would set a dangerous precedent for future trade deals and could scare away would-be supporters of the deal.

“A number of my colleagues share my view that the TPP can be a net positive in the long run,” Tillis wrote. “I am confident, however, that the path toward ratification will be significantly endangered if the administration or one of our trading partners impose their biases by targeting specific industries for exclusion.”

A spokesperson for the U.S. Trade Representative wouldn’t speak directly to the carveout in a statement to CQ Roll Call, saying only that “We are working proactively to promote the interests of American farmers and preventing discrimination against them, while ensuring that the FDA and health authorities of other countries can implement tobacco regulations to protect public health.”